Cardarine (GW501516) | 40mg/1,5 mlCardarine (GW501516) | 40mg/1,5 ml
$116.00
What is Cardarine (GW501516)?
Cardarine, also known as GW501516, is a compound from the PPAR-δ (peroxisome proliferator-activated receptor delta) agonist class. Although often mentioned alongside SARMs, it represents a separate class of compounds focused on the regulation of energy metabolism. GW501516 was developed to study metabolic mechanisms that govern fat burning, glucose balance, and physical endurance.
Cardarine has gained significant attention in scientific contexts due to its ability to influence mitochondrial activity and fatty acid oxidation, thereby supporting the body’s adaptation to increased physical load and caloric deficit. Its profile makes it a valuable subject in research related to improving metabolic efficiency and cardiorespiratory endurance.
Mechanism of action of Cardarine (GW501516):
Cardarine acts by activating PPAR-δ receptors—regulators responsible for controlling the expression of genes involved in fat metabolism, glucose utilization, and cellular energy. Activation of these receptors leads to enhanced fat burning and an improved ability of cells to use oxygen efficiently.
Additionally, GW501516 supports redirecting energy demands from carbohydrates to fats, which is particularly important in research related to endurance and body composition control. Cardarine does not affect androgen receptors, which makes it suitable for studies where hormonal influence needs to be avoided.
Potential research-backed benefits of Cardarine (GW501516):
Cardarine has been the subject of numerous studies in which the following potential effects have been observed:
- Increased fat burning through activation of β-oxidation;
- Improved energy efficiency and aerobic endurance;
- Optimization of glucose metabolism and insulin sensitivity;
- Support for physical activity during caloric deficit;
- Preservation of muscle mass while simultaneously reducing fat;
- Non-hormonal profile, without suppression of testosterone or androgenic activity;
- Suitable for subcutaneous application, with a stabilized formula for controlled absorption.
These characteristics make GW501516 suitable for research related to improving sports endurance, body weight control, and energy regulation.
Comparison of Cardarine (GW501516) with other SARMs and metabolic modulators
Cardarine (GW501516) is a synthetic agonist of the PPAR-δ receptor used in research protocols aimed at fat burning, increased endurance, and improved metabolic efficiency. Although often mentioned alongside SARMs, Cardarine does not interact with androgen receptors; instead, it modulates energy metabolism by activating specific nuclear receptors.
Compared with GW0742, another PPAR-δ agonist, Cardarine has lower selectivity but a better-studied profile. GW0742 is more potent at the receptor level, but Cardarine is more widely used in research models, especially those related to sports physiology, long-duration activity, and glucose control. Cardarine is applied successfully in laboratory settings to evaluate lipid metabolism without directly altering the hormonal profile.
In comparison with Stenabolic (SR9009), which influences REV-ERBα receptors and circadian rhythms, Cardarine acts more centrally on fat metabolism and energy utilization, especially in skeletal muscle. SR9009 shows synergistic potential with Cardarine, but unlike it, does not activate the PPAR pathway directly. Therefore, Cardarine remains preferred in studies focused on sports endurance and lipid control.
In the context of SARMs such as Ostarine or Ligandrol, which target muscle growth, Cardarine serves as a complementary compound—with a different mechanism but a strong role in protocols for body recomposition. It does not stimulate androgenic activity, does not suppress testosterone, and can be used alone or in combination for maximal metabolic efficiency.
Dosage and application of Cardarine (GW501516) in research protocols:
Recommended research scheme: 5 units once daily, for 4–6 weeks, followed by a 2–4 week break period.
1 unit = 26.66mcg.
Total amount in pen: 150 units
Possible side effects of Cardarine (GW501516):
Despite the potential of Cardarine, there are observations of certain side effects, especially with prolonged use or higher doses:
- Insufficient long-term data related to chronic exposure;
- Changes in lipid profile under certain conditions;
- Individual reactions.
Adherence to optimal dosage and control over the duration of application play a key role in limiting the manifestation of side effects.
Disclaimer
For research use only. Not for human consumption.



